Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Post by blackspade799on Jul 23, 2024 2:24pm
108 Views
Post# 36144760

HUGE! 91% support rescheduling or de-scheduling

HUGE! 91% support rescheduling or de-scheduling

Almost unanimous support

Nearly all comments were in favor of rescheduling, according to an analysis conducted by Seattle-based cannabis data platform Headset.

91% of the comments supported rescheduling or requested that the Biden administration take another step and deschedule the drug entirely, Headset said in a Tuesday news release sent by the National Cannabis Industry Association.

“Public health and safety demand a schedule III placement for marijuana,” Michael Bronstein, president of the American Trade Association for Cannabis and Hemp, wrote in his comments, which he shared with MJBizDaily.

https://mjbizdaily.com/marijuana-rescheduling-proposal-generates-nearly-43000-comments/

<< Previous
Bullboard Posts
Next >>